 Part I. Int Angiol. 2018; 37(3):181-254.57

follow-up was short. The review found moderatecertainty evidence that phlebotonics in patients with
CVI probably reduced edema in the lower legs,
compared with placebo (risk ratio [RR] 0.70; 95% conÔ¨Ådence interval [CI] 0.63-0.7